title: Adenovirus mediated CTLA4Ig gene inhibits infiltration of immune cells and cell apoptosis in rats after liver transplantation.
abstract: OBJECTIVE
  To investigate the role of adenovirus-mediated CTLA4Ig gene therapy in inhibiting the infiltration of macrophages and CD8(+) T cells and cell apoptosis after liver transplantation.
  
  
  METHODS
  The rat orthotopic liver transplantation model was applied. The rats were divided into three groups: group I: rejection control (SD-to-Wistar); group II: acute rejection treated with intramuscular injection of CsA 3.0 mg/(kg x d) for 12 d (SD-to-Wistar+CsA); groupIII: injection of 1 x 10(9) PFU adenovirus-mediated CTLA4Ig gene liquor in dorsal vein of penis 7 d before liver transplantation (SD-to-Wistar+CTLA4Ig). Immunohistochemistry and transferase-mediated dUTP nick-end labeling (TUNEL) were used to analyze the expression of CTLA4Ig gene in liver, infiltration of macrophages and CD8(+) T cells, cell apoptosis in grafts at different time-points after liver transplantation. Histopathological examination was done.
  
  
  RESULTS
  CTLA4Ig gene expression was positive in liver on d 7 after administering adenovirus-mediated CTLA4Ig gene via vein, and remained positive until day 60 after liver transplantation. Infiltration of macrophages and CD8(+) T cells in CTLA4Ig-treated group was less than in rejection control group and CsA-treated group. The apoptotic index of rejection group on d 3, 5, and 7 were significantly higher than that of CTLA4Ig-treated group. A good correlation was found between severity of rejection reaction and infiltration of immune activator cells or cell apoptotic index in grafts.
  
  
  CONCLUSIONS
  CTLA4Ig gene is constantly expressed in liver and plays an important role in inducing immune tolerance.
authors.affiliation: Ministry of Public Health, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China. jiangguoping@hotmail.com
authors.forename: Guo-Ping
authors.initials: GP
authors.lastname: Jiang
authors.forename: Zhen-Hua
authors.initials: ZH
authors.lastname: Hu
authors.forename: Shu-Sen
authors.initials: SS
authors.lastname: Zheng
authors.forename: Chang-Ku
authors.initials: CK
authors.lastname: Jia
authors.forename: Ai-Bin
authors.initials: AB
authors.lastname: Zhang
authors.forename: Wei-Lin
authors.initials: WL
authors.lastname: Wang
mesh_terms: D000069594:Abatacept; D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D017209:Apoptosis / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000473:pathology; D015316:Genetic Therapy; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D018796:Immunoconjugates / Q000235:genetics*; D007167:Immunotherapy; D008099:Liver / Q000276:immunology / Q000473:pathology; D016031:Liver Transplantation / Q000401:mortality; D008264:Macrophages / Q000276:immunology / Q000473:pathology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D016019:Survival Analysis
chemical_list: D018796:Immunoconjugates; D000069594:Abatacept
references.citation: J Clin Invest. 2000 Mar;105(5):643-51
references.pmid: 10712436
references.citation: Am J Transplant. 2002 Mar;2(3):223-8
references.pmid: 12096784
references.citation: Transplant Proc. 2003 Feb;35(1):456-7
references.pmid: 12591485
references.citation: Hum Pathol. 1989 Feb;20(2):132-43
references.pmid: 2644165
references.citation: Surgery. 1983 Jan;93(1 Pt 1):64-9
references.pmid: 6336859
references.citation: Transplantation. 2003 Apr 27;75(8):1374-9
references.pmid: 12717233
references.citation: Transplantation. 1998 May 27;65(10):1370-7
references.pmid: 9625021
references.citation: Liver. 2001 Feb;21(1):13-7
references.pmid: 11169067
references.citation: Arthritis Rheum. 2000 Aug;43(8):1688-97
references.pmid: 10943858
references.citation: Hepatobiliary Pancreat Dis Int. 2004 May;3(2):170-4
references.pmid: 15138103
references.citation: J Clin Invest. 2001 Mar;107(5):575-83
references.pmid: 11238558
references.citation: J Clin Invest. 2002 Jun;109(11):1471-9
references.pmid: 12045261
references.citation: Hum Gene Ther. 2003 Apr 10;14(6):561-75
references.pmid: 12718766
references.citation: World J Gastroenterol. 2001 Aug;7(4):445-54
references.pmid: 11819809
references.citation: J Exp Med. 1993 Nov 1;178(5):1801-6
references.pmid: 8228826
references.citation: J Immunother. 1999 Sep;22(5):381-9
references.pmid: 10546153
references.citation: Transplant Proc. 1997 Jun;29(4):2212
references.pmid: 9193596
references.citation: Hum Immunol. 2002 Oct;63(10):853-61
references.pmid: 12368037
references.citation: J Immunol. 2000 May 15;164(10):5258-68
references.pmid: 10799887
references.citation: J Clin Invest. 2000 Jul;106(1):91-101
references.pmid: 10880052
references.citation: J Clin Immunol. 2002 Jan;22(1):1-7
references.pmid: 11958588
references.citation: Transplantation. 2003 Feb 15;75(3):303-8
references.pmid: 12589149
references.citation: Transplantation. 2004 Jan 15;77(1):48-54
references.pmid: 14724434
references.citation: Transplantation. 1999 Oct 15;68(7):1010-8
references.pmid: 10532543
references.citation: Bone Marrow Transplant. 2001 Jun;27(12):1263-73
references.pmid: 11548844
references.citation: Hokkaido Igaku Zasshi. 1999 Nov;74(6):467-75
references.pmid: 10642893
references.citation: J Exp Med. 1991 Sep 1;174(3):561-9
references.pmid: 1714933
references.citation: Transplant Proc. 1997 Feb-Mar;29(1-2):177-8
references.pmid: 9122951
references.citation: Transplant Proc. 2001 Feb-Mar;33(1-2):226
references.pmid: 11266790
references.citation: Nat Med. 1998 Oct;4(10):1185-8
references.pmid: 9771754